New Sizes Approved for Cordis' Sleek OTW Platform

June 24, 2013—Cordis Corporation (Bridgewater, NJ) announced the European CE Mark approval and US Food and Drug Administration (FDA) approval of additional sizes of the company's Sleek over-the-wire (OTW) platform, a 0.014-inch, ultra-low-profile percutaneous transluminal angioplasty dilatation catheter for below-the-knee procedures. The Sleek OTW catheter was first launched globally in 2011. Cordis will immediately start commercializing these new sizes in various countries around the world.

According to Cordis, the product line extension includes additional lengths of 20 mm and 280 mm for most of its current diameters. The 280-mm length will enable physicians to treat diffuse disease with fewer inflations. The Sleek OTW peripheral balloon catheter offers an ultra-low-profile, 1.25-mm diameter option. The device provides excellent pushability with a small crossing profile that helps physicians restore blood flow to the lower limbs, the company stated.

William Wu, MD, from the Heart and Vascular Clinic of San Antonio in Texas, commented on the Sleek OTW device in the company's press release. He stated, “The Sleek OTW catheter has enabled me to treat patients with severe chronic limb ischemia using the angiosome concept. Now more than ever, with the new expanded sizes, we will be able to effectively treat extremely distal lower-leg peripheral vascular disease using fewer inflations. I look forward to continue working with Cordis as they bring more products to market that will help provide safe and optimal outcomes for patients.”